Hunan Hansen Pharmaceutical Co., Ltd. Stock Price

SZSE:002412 Community·CN¥3.4b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

002412 Share Price Performance

CN¥0

-5.71 (-100.00%)

CN¥0

-5.71 (-100.00%)

CN¥0

Tue, 26 May 26

Share Pricen/a

002412 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks

1 Reward

View Full Analysis

Hunan Hansen Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 0.34
: 76.43%
: 16.36%
: 2.4%

View Full Analysis

About 002412

Founded: n/a
Employees: 1675
CEO: Zhengqing Liu
WebsiteView website: www.hansenzy.com

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.